• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

PEMBROLIZUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

PARKINSON DISEASE RHEUMATOID ARTHRITIS CLOSTRIDIUM DIFFICILE CELL DIVISION CASP3 CD4 LISTERIA MONOCYTOGENES REMICADE ESCHERICHIA COLI IL23A INFLAMMATION DOXORUBICIN RECEPTOR 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IL17A CANCER IFNG HELICOBACTER PYLORI CTLA4 ANGIOGENESIS CELL DIFFERENTIATION AUTOPHAGY IMMUNE RESPONSE INSULIN FOXP3 STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PNEUMONIAE PSEUDOMONAS AERUGINOSA AGING DIABETES MELLITUS NEURODEGENERATIVE DISORDERS BREAST CANCER METFORMIN ALZHEIMER'S DISEASE TNF PORPHYROMONAS GINGIVALIS TH17 CELLS CANDIDA ALBICANS CELL PROLIFERATION SOD1 IL6 APOPTOTIC PROCESS ERBB-2 TP53 CELL DEATH

© 2020 Biovista Vizit All Rights Reserved.